MiniMed Group (MMED) officer Gyurci John submits initial Form 3

Rhea-AI Filing Summary

MiniMed Group, Inc. officer Gyurci John filed an initial Form 3 reporting his status as a company officer. This is a baseline ownership filing required when someone becomes subject to insider reporting rules. The filing does not report any transactions or derivatives positions in MiniMed Group stock.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gyurci John

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Vice President. Chief Accounting Officer Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the MiniMed Group (MMED) Form 3 for Gyurci John show?

The Form 3 shows that Gyurci John is an officer of MiniMed Group, Inc. and has become subject to insider reporting rules. It is an initial ownership statement and reports no stock transactions or derivative positions.

Are there any MiniMed Group (MMED) insider stock trades in this Form 3?

No, this Form 3 reports no insider stock trades by Gyurci John. All transaction counts and share amounts in the summary are zero, indicating no reported purchases, sales, or derivative exercises at the time of this filing.

What type of filing is MiniMed Group (MMED) reporting for Gyurci John?

MiniMed Group filed a Form 3 for officer Gyurci John. Form 3 is an initial statement of beneficial ownership required when someone becomes a company insider, before any ongoing Form 4 or Form 5 transaction reporting begins.

Does the MiniMed Group (MMED) Form 3 disclose derivative securities for Gyurci John?

No, the Form 3 shows no derivative securities for Gyurci John. The derivative summary is empty and the derivative transaction count is zero, indicating no options, warrants, or similar instruments reported in this filing.

What does the transaction summary in the MiniMed Group (MMED) Form 3 indicate?

The transaction summary shows zero buys, zero sells, and zero exercises, with net buy-sell direction listed as neutral. This confirms the filing serves only as an initial ownership statement without any concurrent trading activity.